Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ONON vs GSK✓SelectedUSD · GSKONON vs GSK performance historyLatest closeAs of-2.59%11/16
Stock and ETF performance explorer

ONON vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-6.4%
GSK return
+58.6%
Excess return
-65.0%
Maximum drawdown
-68.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.6%-0.1%-2.5%-2.6%
7D-12.7%-1.3%-11.4%-12.5%
30D-5.7%+2.7%-8.5%-6.2%
3M+1.7%+2.7%-1.0%+1.1%
6M-12.1%+3.3%-15.4%-12.6%
YTD-29.5%+6.5%-36.0%-30.5%
1Y-22.7%+10.7%-33.4%-24.3%
3Y+20.8%+64.4%-43.6%+4.3%
5Y-28.2%+46.7%-74.9%-38.4%
All-6.4%+58.6%-65.0%-21.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling